Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The Influence of Clinical T Factor on Predicting Pathologic N Factor in Resected Lung Cancer.

Shimamatsu S, Takenoyama M, Shimokawa M, Takada K, Edagawa M, Toyozawa R, Nosaki K, Oba T, Tagawa T, Yamaguchi M, Taguchi K, Seto T.

Ann Thorac Surg. 2019 Oct;108(4):1080-1086. doi: 10.1016/j.athoracsur.2019.04.026. Epub 2019 May 16.

PMID:
31103386
2.

Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?

Yamaguchi M, Shimamatsu S, Edagawa M, Hirai F, Toyozawa R, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Today. 2019 Mar;49(3):197-205. doi: 10.1007/s00595-018-1751-7. Epub 2019 Jan 4.

PMID:
30610361
3.

A case of different EGFR mutations in surgically resected synchronous triple lung cancer.

Haratake N, Takenoyama M, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y.

J Thorac Dis. 2018 Apr;10(4):E255-E259. doi: 10.21037/jtd.2018.03.105.

4.

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.

Katsura M, Shoji F, Okamoto T, Shimamatsu S, Hirai F, Toyokawa G, Morodomi Y, Tagawa T, Oda Y, Maehara Y.

Cancer Sci. 2018 Jan;109(1):154-165. doi: 10.1111/cas.13422. Epub 2017 Nov 9.

5.

A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report.

Yamaguchi M, Hirai F, Taguchi K, Toyozawa R, Edagawa M, Shimamatsu S, Nosaki K, Seto T, Takenoyama M, Ichinose Y.

Surg Case Rep. 2017 Oct 4;3(1):108. doi: 10.1186/s40792-017-0382-3.

6.

Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case report.

Edagawa M, Haratake N, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Kaneko K, Seto T, Takenoyama M, Ichinose Y.

J Thorac Dis. 2017 Aug;9(8):E689-E693. doi: 10.21037/jtd.2017.07.90.

7.

Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type.

Hirai F, Edagawa M, Shimamatsu S, Toyozawa R, Toyokawa G, Nosaki K, Yamaguchi M, Seto T, Takenoyama M, Ichinose Y.

Oncol Lett. 2017 Jul;14(1):306-312. doi: 10.3892/ol.2017.6118. Epub 2017 May 4.

8.

Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report.

Takamori S, Yamaguchi M, Taguchi K, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Seto T, Takenoyama M, Ichinose Y.

Surg Case Rep. 2017 Dec;3(1):46. doi: 10.1186/s40792-017-0322-2. Epub 2017 Mar 20.

9.

The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma.

Takamori S, Toyokawa G, Taguchi K, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Seto T, Hirai F, Yamaguchi M, Shoji F, Okamoto T, Takenoyama M, Ichinose Y.

Clin Lung Cancer. 2017 Jul;18(4):e303-e313. doi: 10.1016/j.cllc.2017.01.008. Epub 2017 Feb 2.

PMID:
28274690
10.

The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma.

Toyokawa G, Taguchi K, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Shimokawa M, Seto T, Takenoyama M, Hamamoto R, Sugio K, Ichinose Y.

Anticancer Res. 2016 Sep;36(9):4841-6.

PMID:
27630338
11.

Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.

Shimamatsu S, Okamoto T, Haro A, Kitahara H, Kohno M, Morodomi Y, Tagawa T, Okano S, Oda Y, Maehara Y.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):1012-1020. Epub 2016 Sep 6.

PMID:
27600618
12.

Prognostic Impact of EGFR Driver Mutations on Postoperative Disease Recurrence in Lung Adenocarcinoma.

Okamoto T, Kitahara H, Shimamatsu S, Katsura M, Takada K, Fujishita T, Suzuki Y, Morodomi Y, Tagawa T, Maehara Y.

Anticancer Res. 2016 Jun;36(6):3057-63.

PMID:
27272827
13.

c-kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report.

Hirai F, Edagawa M, Shimamatsu S, Toyozawa R, Toyokawa G, Nosaki K, Yamaguchi M, Seto T, Twakenoyama M, Ichinose Y.

Mol Clin Oncol. 2016 Apr;4(4):527-529. Epub 2016 Jan 28.

14.

PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.

Ikeda S, Okamoto T, Okano S, Umemoto Y, Tagawa T, Morodomi Y, Kohno M, Shimamatsu S, Kitahara H, Suzuki Y, Fujishita T, Maehara Y.

J Thorac Oncol. 2016 Jan;11(1):62-71. doi: 10.1016/j.jtho.2015.09.010.

15.

How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.

Yamaguchi M, Furuya A, Edagawa M, Taguchi K, Shimamatsu S, Toyokawa G, Toyozawa R, Nosaki K, Hirai F, Seto T, Takenoyama M, Ichinose Y.

Surg Oncol. 2015 Sep;24(3):258-63. doi: 10.1016/j.suronc.2015.08.004. Epub 2015 Aug 13.

PMID:
26298200
16.

Surgical results of resectable small cell lung cancer.

Kawano D, Okamoto T, Fujishita T, Suzuki Y, Kitahara H, Shimamatsu S, Maehara Y.

Thorac Cancer. 2015 Mar;6(2):141-5. doi: 10.1111/1759-7714.12154. Epub 2015 Mar 2.

17.

Solitary pulmonary metastasis from malignant melanoma of the bulbar conjunctiva presenting as a pulmonary ground glass nodule: Report of a case.

Mizuuchi H, Suda K, Kitahara H, Shimamatsu S, Kohno M, Okamoto T, Maehara Y.

Thorac Cancer. 2015 Jan;6(1):97-100. doi: 10.1111/1759-7714.12124. Epub 2015 Jan 7.

18.

Underlying Problems in Surgical Treatment of cT1-2N1 Non-Small Cell Lung Cancer.

Okamoto T, Tagawa T, Morodomi Y, Shimamatsu S, Kitahara H, Maehara Y.

Thorac Cardiovasc Surg. 2017 Mar;65(2):130-135. doi: 10.1055/s-0035-1558648. Epub 2015 Aug 10.

PMID:
26258472
19.

Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib.

Toyokawa G, Inamasu E, Shimamatsu S, Yoshida T, Nosaki K, Hirai F, Yamaguchi M, Seto T, Takenoyama M, Ichinose Y.

J Thorac Oncol. 2015 Jul;10(7):e55-7. doi: 10.1097/JTO.0000000000000509. No abstract available.

20.

Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.

Yamaguchi M, Ichinose Y, Shimamatsu S, Yoshida T, Toyokawa G, Nosaki K, Hirai F, Seto T, Takenoyama M.

Surg Oncol. 2015 Jun;24(2):78-83. doi: 10.1016/j.suronc.2015.02.004. Epub 2015 Mar 26.

PMID:
25818753
21.

Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer.

Morodomi Y, Okamoto T, Kohno M, Katsura M, Takada K, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Yoshida T, Tagawa T, Okano S, Maehara Y.

Anticancer Res. 2015 Mar;35(3):1791-6.

PMID:
25750344
22.

Applicability of Pulmonary Lobectomy in Treating Metastatic Lung Tumors.

Okamoto T, Kitahara H, Shimamatsu S, Morodomi Y, Tagawa T, Maehara Y.

Ann Thorac Cardiovasc Surg. 2015;21(3):189-93. doi: 10.5761/atcs.oa.14-00183. Epub 2015 Jan 26.

23.

Clinical Significance of Detecting Somatic Gene Mutations in Surgically Resected Adenosquamous Cell Carcinoma of the Lung in Japanese Patients.

Morodomi Y, Okamoto T, Takenoyama M, Takada K, Katsura M, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Kohno M, Tagawa T, Okano S, Taguchi K, Ichinose Y, Maehara Y.

Ann Surg Oncol. 2015 Aug;22(8):2593-8. doi: 10.1245/s10434-014-4218-0. Epub 2014 Nov 6.

PMID:
25373537
24.

Successful resection of a giant mediastinal non-seminomatous germ cell tumor showing fluorodeoxyglucose accumulation after neoadjuvant chemotherapy: report of a case.

Takada K, Morodomi Y, Okamoto T, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Kohno M, Kawano D, Hidaka N, Nakanishi Y, Maehara Y.

Fukuoka Igaku Zasshi. 2014 May;105(5):117-23.

PMID:
25283008
25.

A rare case of a bronchial anomaly running in the hilar region from the right lower lobe to the middle lobe.

Fujishita T, Okamoto T, Suzuki Y, Kitahara H, Shimamatsu S, Kohno M, Morodomi Y, Kawano D, Matsuo Y, Honda H, Maehara Y.

Fukuoka Igaku Zasshi. 2014 Apr;105(4):100-4.

PMID:
25076781
26.

The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.

Okamoto T, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Kohno M, Morodomi Y, Kawano D, Maehara Y.

Lung Cancer. 2014 Aug;85(2):125-30. doi: 10.1016/j.lungcan.2014.06.006. Epub 2014 Jun 16.

PMID:
24976334
27.

Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations.

Kohno M, Okamoto T, Suda K, Shimokawa M, Kitahara H, Shimamatsu S, Konishi H, Yoshida T, Takenoyama M, Yano T, Maehara Y.

Clin Cancer Res. 2014 Jul 1;20(13):3613-22. doi: 10.1158/1078-0432.CCR-13-2683. Epub 2014 May 6.

28.

[A case of surgical treatment for a bilateral pneumothorax that occurred in a patient with severe asbestosis and advanced emphysema].

Kurihara T, Kawano D, Okamoto T, Fujishita T, Suzuki Y, Kitahara H, Shimamatsu S, Kouno M, Morodomi Y, Maehara Y.

Fukuoka Igaku Zasshi. 2014 Jan;105(1):28-31. Japanese.

PMID:
24800531
29.

[Case of adenocarcinoma in situ accompanied by an intrapulmonary lymph node with a sarcoid-like reaction].

Kawano D, Okamoto T, Morodomi Y, Kono M, Shimamatsu S, Kitahara H, Kawasaki J, Miyazaki M, Yamagata M, Sonoda T.

Fukuoka Igaku Zasshi. 2013 Oct;104(10):394-6. Japanese.

PMID:
24511672
30.

Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.

Suda K, Tomizawa K, Mizuuchi H, Ito S, Kitahara H, Shimamatsu S, Kohno M, Yoshida T, Okamoto T, Maehara Y, Yatabe Y, Mitsudomi T.

Aging Dis. 2012 Dec;3(6):438-43. Epub 2012 Oct 23.

Supplemental Content

Loading ...
Support Center